How to Succeed in the Pharma Industry: Conversations with Instructors at MMS Academy Part 2

Part 2: Statistical Programming & Compliance

We sat down with the instructors for MMS Academy, MMS’ learning arm, for some advice on how to be successful to help those looking to work in the pharma industry.

In our first article, we talked with our instructors for medical writing and pharmacovigilance. This article, Part 2, features advice from our statistical programming and quality and compliance instructors.

Succeeding in Statistical Programming

Senthil Kumar, Senior Manager of Statistical Programming, has over 14 years of programming experience with complex SAS data steps and procedures and over 11 years of experience leading a program team of 10. He said a successful clinical programmer should have a blend of these attributes:

  • SAS technical skills
  • Understanding of clinical trials
  • Basic understanding of statistics in clinical trials
  • Industry standards and guidelines
  • Analyst mindset (planning, execution, problem solving and decision-making skills)
  • Soft skills (communication skills and basic etiquette)
  • Industry collaboration (conferences, microblogging sites, etc)

Kelly Williams, Principal Statistical Programmer has extensive experience in programming and statistics and leading project teams for large submissions. Here’s what she thinks future clinical statistical programmers should know.

“If you are considering a career as a clinical statistical programmer in the industry, it would be very beneficial to have a degree in STEM.  In addition, you must be CURIOUS, flexible, and seeking a career of lifelong learning.  The pace is often fast and seemingly ever changing!  You must enjoy and embrace this!”

Saichand Satyavarapu, Senior Manager of Statistical Programming has over 13 years of programming experience, including the creation of complex SAS data steps and procedures. Here’s his advice:

“Are you from a science background, have good computer and analytical skills? Are you highly ambitious but unsure which direction to take? Clinical Programming is the place for you!”

Succeeding in Quality & Compliance

Jennifer Perrin, Associate Director of Quality and Compliance, has over 20 years of pharma industry experience ensuring organizations achieve regulatory compliance. She has four suggestions for those looking to enter the field of quality and compliance:

  1. Earn a bachelor’s degree in a science field
  2. Seek to understand and then to be understood
  3. Always pay attention to the details
  4. Understand that Quality and Compliance are support functions

Sharon Barattini, Senior Quality and Compliance Specialist, has over 30 years of experience in quality and compliance roles. She says for those interested in a career in quality and compliance, they should:

  • Read regulations and standards.
  • Research the application of those regulations and standards.
  • Apply what you’ve learned.
  • Hone your communication skills.
  • Be disciplined with good attention to detail and strong interpersonal communication skills as you will need to build professional relationships to create success in the clinical research realm.

Sign up for courses here.

Suggested For You

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives

July 9th, 2024

Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line

perspectives

July 2nd, 2024

Part 1: RWD Noninterventional Study Design and FDA Engagement Opportunity for Early Stage Oncology

perspectives

June 21st, 2024

Peer-Reviewed Journal Articles: The Crucial Role of Publication in the Pharmaceutical Industry

perspectives

June 14th, 2024

A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry

perspectives

June 6th, 2024

Datacise and Diversity in Patient Enrollment: Combining Geospatial and Demographic Data to Aid Site Selection

perspectives

May 29th, 2024

Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules

perspectives

May 21st, 2024

Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of “Nonmedical Use” On Labelling

perspectives

May 10th, 2024

Psychedelics in Drug Development and Regulatory Considerations Part I: Benefit-Risk

perspectives

April 29th, 2024

Validation of Clinical Dashboards for Decision Making